articleNatureOct 30, 2019Closed access

The clinical KRAS(G12C) inhibitor AMG 510 drives anti-tumour immunity

JCJude CanonKRKaren RexAYAnne Y. SaikiCMChristopher MohrKSKeegan S. Cooke

Amgen (United States) · Pfizer (United States) · +10 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

2,241
total citations
FWCI
190.08
Percentile
100%
References
34
Citations per year

Authors

34

Topics & keywords

Topics
Keywords
  • KRAS
  • Cancer research
  • Pharmacology
  • Immune system
  • Medicine
  • Cancer
  • Immunology
  • Colorectal cancer
No related works found for this paper.